BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10037541)

  • 1. The psychosexual impact of human papillomavirus cervical infections.
    Reed BD; Ruffin MT; Gorenflo DW; Zazove P
    J Fam Pract; 1999 Feb; 48(2):110-6. PubMed ID: 10037541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
    Nielsen A; Kjaer SK; Munk C; Iftner T
    Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse).
    Kjaer SK; Chackerian B; van den Brule AJ; Svare EI; Paull G; Walbomers JM; Schiller JT; Bock JE; Sherman ME; Lowy DR; Meijer CL
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):101-6. PubMed ID: 11219765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grujnberga V; Grujnberg A; Juschenko A; Johansson B; Tosi P; Cintorino M; Santopietro R; Syrjänen K
    Sex Transm Dis; 2003 Sep; 30(9):680-4. PubMed ID: 12972789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.
    Kahn JA; Slap GB; Bernstein DI; Kollar LM; Tissot AM; Hillard PA; Rosenthal SL
    J Womens Health (Larchmt); 2005 Sep; 14(7):650-9. PubMed ID: 16181021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for Clamydia infections of the genital organs in adolescent females].
    Sedlecki K; Markovic M; Rajic G
    Srp Arh Celok Lek; 2001; 129(7-8):169-74. PubMed ID: 11797445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.
    Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Lo SS; Lee PW; Ngan HY
    BJOG; 2009 Mar; 116(4):501-10. PubMed ID: 19250361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of risk factors, severity, and treatment of women with genital HPV.
    Kenney JW
    Cancer Nurs; 1994 Aug; 17(4):308-17. PubMed ID: 7954378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions.
    Wang KL; Jeng CJ; Yang YC; Chen CA; Cheng WF; Chen TC; Mast TC; Wang YC; Hsieh CY
    J Psychosom Obstet Gynaecol; 2010 Mar; 31(1):16-23. PubMed ID: 20121461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
    Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
    J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
    Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with human papillomavirus infection in women encountered in community-based offices.
    Reed BD; Zazove P; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT
    Arch Fam Med; 1993 Dec; 2(12):1239-48. PubMed ID: 8130905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
    Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials.
    Paavonen J;
    Curr Med Res Opin; 2008 Jun; 24(6):1623-34. PubMed ID: 18435868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's desired information about human papillomavirus.
    Anhang R; Wright TC; Smock L; Goldie SJ
    Cancer; 2004 Jan; 100(2):315-20. PubMed ID: 14716766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.